RMD

ResMed Inc.

HealthcareMedical - DevicesUSUSDPeers →

$188.45

-0.15%LiveJun 22, 2026

AI Brief

Market cap

$27.34B

52w range

180.27 – 293.81

P / E

—

EPS · FY 2025

$9.51

Volume

1.12M

Revenue · FY 2025

$5.15B

+9.84% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on ResMed Inc.’s valuation

decile 7 · 9% factors bull

News pulse · 14d

4 storiesPositive +0.38All news →

06-09today

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$188.63

Change

-25.89%

Period high

$293.73

Period low

$182.82

Period start

$254.522025-06-23

Through 2026-06-18

Fair value

Football field →

Weighted blend

$443.31

+135.24% vs spot

Recommendation

Strong Buy

18 of 19 methods

Method spread

7bull11bear

±5% threshold

Analyst PT consensus: $281.29 (+49.27%)

Candlestick · 1Y

Open in chart workstation →

RMD

188.63-25.89%

H 293.81L 180.27MA50 207.07MA200 242.57Avg vol 1.1M

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.10%	-0.82%	-9.42%	-16.61%	-23.60%	-21.76%	-25.96%	-12.96%	-21.83%	+202.34%	+27948.16%

Insider · 30d

History →

Bought

0 txns

Sold

$5.97M

10 txns

Net flow

−$5.97M

Aftermarket

Live

Jun 22, 08:36 PM

Last trade

$189.45

602 sh

Bid

$181.60

1 sh

Ask

$191.00

20 sh

Spread

$9.400

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q3 Mar 2026	$1.43B	$398.73M	$2.71
Q2 Dec 2025	$1.42B	$392.59M	$2.68
Q1 Sep 2025	$1.34B	$348.54M	$2.37
Q4 Jun 2025	$1.35B	$379.71M	$2.58
Q3 Mar 2025	$1.29B	$365.04M	$2.48
Q2 Dec 2024	$1.28B	$344.62M	$2.34

Sector & industry today

Live

Sectors

Real Estate
+1.28%
Industrials
+1.01%
Basic Materials
+0.65%
Energy
+0.59%
Healthcare
+0.03%
Utilities
-0.09%
Financial Services
-0.18%
Communication Services
-0.56%
Technology
-0.77%
Consumer Cyclical
-0.83%
Consumer Defensive
-0.98%

Top industries (issuer's industry highlighted)

Medical - Devices
-0.38%
Biotechnology
+7.27%
Software - Services
-5.92%
Electronic Gaming & Multimedia
-3.76%
Financial - Mortgages
-3.51%
Software - Infrastructure
-3.12%
Electrical Equipment & Parts
+2.70%
Staffing & Employment Services
-2.69%
Apparel - Footwear & Accessories
-2.61%
Coal
-2.36%
Advertising Agencies
+2.35%
Engineering & Construction
+2.33%

Analyst view

DB · price_targets + analyst_grades

Consensus target

$281.29

+48.72% upside

Low

$225.00

Median

$275.00

High

$345.00

Recent actions

0 ↑0 ↓8 hold

May 01, 2026
Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026

News

DB · news_items

Recent analyst activity

2 latest

Jun 22, 2026PT$266.00ResMed price target lowered to $266 from $290 at KeyBancKeyBanc
Jun 17, 2026PT$230.00Morgan Stanley Downgrades ResMed (RMD) to EqualweightMorgan Stanley

Peers

Total assets

$8.17B

Total debt

$851.81M

Cash & equiv

$1.21B

Operating CF

$1.75B

Free cash flow

$1.66B

Buybacks

-$300.03M

Recent insiders

All →

Insider	Action	Shares	Value	Date
Farrell Michael J. director, officer: Chairman and CEO	Sell	4,991	$1.13M	Apr 07, 2026
Sandercock Brett officer: Chief Financial Officer	Sell	1,000	$224.31K	Apr 01, 2026
FARRELL PETER C director	Sell	2,000	$450K	Apr 01, 2026
Farrell Michael J. director, officer: Chairman and CEO	Sell	4,991	$1.25M	Mar 09, 2026
FARRELL PETER C director	Sell	2,000	$520.44K	Mar 04, 2026
Sandercock Brett officer: Chief Financial Officer	Sell	1,000	$254.3K	Mar 02, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$5.15B	$1.69B	$1.4B	$9.51	+27.22%
FY 2024	$4.69B	$1.32B	$1.02B	$6.92	+21.79%
FY 2023	$4.22B	$1.13B	$897.56M	$6.09	+21.25%
FY 2022	$3.58B	$1B	$779.44M	$5.30	+21.78%
FY 2021	$3.2B	$903.68M	$474.51M	$3.24	+14.84%